Prostate-Specific Membrane Antigen Imaging for Patients with Prostate Cancer
Customize your policy alerts
Sign up for Mass General Brigham Health Plan Policy 049 alerts
Get alerted when Policy 049 changes without checking for updates manually.
Monitor payer policy activity
This policy governs medical necessity and prior authorization for PSMA-targeted PET imaging, with or without CT, in adult members with prostate cancer, including plan-specific requirements for Medicare Advantage, Mass General Brigham ACO, One Care/SCO, and Commercial and Qualified Health Plan members.
The policy criteria were updated in July 2025 based on the latest NCCN guidelines.
Gozellix was added to the policy information and code list in February 2026.
The prior authorization table and member-plan variations were updated in January 2026.
The code list was updated during the November 1, 2026 ad hoc review.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.